WHO Inspection Follow-Up: CAPA and Compliance Monitoring
WHO Inspection Follow-Up: CAPA and Compliance Monitoring WHO Inspection Follow-Up: Managing CAPA and Ensuring GMP Compliance The conclusion of a WHO GMP inspection does not mark the end of the evaluation process—it signals the beginning of a critical compliance phase. Pharmaceutical manufacturers must respond to observations through structured Corrective and Preventive Action (CAPA) plans and…
Read More “WHO Inspection Follow-Up: CAPA and Compliance Monitoring” »